CONTRI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.119
AS - Asia 1.040
EU - Europa 656
SA - Sud America 190
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 63
OC - Oceania 23
Totale 3.161
Nazione #
US - Stati Uniti d'America 1.042
IT - Italia 325
SG - Singapore 321
CN - Cina 178
BR - Brasile 126
VN - Vietnam 121
HK - Hong Kong 86
BD - Bangladesh 84
FR - Francia 67
GB - Regno Unito 55
DE - Germania 50
CA - Canada 49
JP - Giappone 49
IN - India 38
EG - Egitto 34
CO - Colombia 29
SE - Svezia 24
CH - Svizzera 21
ID - Indonesia 20
NL - Olanda 20
RU - Federazione Russa 18
AR - Argentina 17
ZA - Sudafrica 17
IR - Iran 15
MX - Messico 14
TR - Turchia 14
NZ - Nuova Zelanda 13
IL - Israele 12
PK - Pakistan 12
IQ - Iraq 11
AU - Australia 10
ES - Italia 10
KR - Corea 10
KZ - Kazakistan 9
PH - Filippine 9
BE - Belgio 8
IE - Irlanda 8
PL - Polonia 8
FI - Finlandia 7
MY - Malesia 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
EC - Ecuador 6
AT - Austria 5
KE - Kenya 5
MA - Marocco 5
PS - Palestinian Territory 4
RS - Serbia 4
UA - Ucraina 4
CR - Costa Rica 3
GR - Grecia 3
JO - Giordania 3
KW - Kuwait 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LT - Lituania 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
HU - Ungheria 1
JM - Giamaica 1
LK - Sri Lanka 1
MK - Macedonia 1
MT - Malta 1
OM - Oman 1
PR - Porto Rico 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.098
Città #
Singapore 203
Ashburn 190
San Jose 138
Council Bluffs 101
Hong Kong 82
Beijing 51
New York 49
Santa Clara 44
Los Angeles 43
Tokyo 36
Ho Chi Minh City 33
Cairo 29
Hanoi 29
Meridian 28
Milan 28
Ferrara 27
Albosaggia 24
Naples 21
Munich 20
Jakarta 18
Lauterbourg 18
Bogotá 17
Shanghai 16
São Paulo 16
Toronto 16
Montreal 15
Denver 14
Zurich 14
Bari 12
Buffalo 12
Chennai 12
Dallas 12
Rome 12
Bologna 11
Chandler 11
Hefei 11
Da Nang 10
Manchester 10
Chicago 9
Orem 9
Tannowa 9
Tucson 9
Almaty 8
Brooklyn 8
Galway 8
Medellín 8
Phoenix 8
Ankara 7
Johannesburg 7
Malonne 7
Warsaw 7
Atlanta 6
Campinas 6
Haiphong 6
Livorno 6
Louisville 6
Tashkent 6
Venice 6
Azusa 5
Baghdad 5
Boston 5
Chattanooga 5
Christchurch 5
Curitiba 5
Dresden 5
Dunedin 5
Florence 5
Frankfurt am Main 5
Geneva 5
Madrid 5
Newark 5
Parma 5
Rio de Janeiro 5
Tel Aviv 5
Auburn 4
Charlotte 4
Falkenstein 4
Kuala Lumpur 4
Lahore 4
London 4
Melbourne 4
Moscow 4
Nairobi 4
Nashville 4
Pisa 4
Poplar 4
Redondo Beach 4
Salt Lake City 4
San Diego 4
Taranto 4
The Dalles 4
Vienna 4
Athens 3
Auckland 3
Belo Horizonte 3
Blumenau 3
Boardman 3
Brisbane 3
Bristol 3
Can Tho 3
Totale 1.755
Nome #
Pharmacological characterization of new modulators of the endocannabinoid system: from single target to multi-target compounds 786
Adenosine and inflammation: Here, there and everywhere 168
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 167
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 166
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 164
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 150
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 144
Pharmacology of Adenosine Receptors: Recent Advancements 141
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 137
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 128
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 126
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 126
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 123
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 119
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 114
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 113
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study. 103
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 68
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy 59
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells 46
In Vitro Radiobiological Evaluation of [64Cu]CuCl2 for Theranostic Applications 13
Totale 3.161
Categoria #
all - tutte 12.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.025


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 0 0 0 0 7 0 0 8 3
2022/202331 3 5 0 3 2 3 6 2 3 0 3 1
2023/2024203 5 3 4 1 20 0 3 3 4 58 43 59
2024/2025752 42 52 53 39 58 74 49 53 111 68 82 71
2025/20261.938 180 72 153 178 254 127 179 136 159 240 168 92
2026/2027219 83 93 43 0 0 0 0 0 0 0 0 0
Totale 3.161